Herbalife Plans $1.55 Billion Debt Refinancing Package
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 23 2026
0mins
Should l Buy HLF?
Source: seekingalpha
- Financing Plan: Herbalife announced a plan to refinance its senior secured debt with a targeted $1.55 billion financing package, which includes a $425 million revolving credit facility, a $125 million Term Loan A, a $500 million Term Loan B, and $500 million of other secured debt, aimed at extending its debt maturity profile.
- Debt Restructuring Details: The company has initiated the refinancing process for its Term Loan B due in April 2029, under which $370 million was outstanding as of December 31, 2025, and this restructuring is expected to enhance the company's financial flexibility.
- Transaction Risk Warning: Herbalife noted that the proposed transactions are subject to customary closing conditions, and there is no assurance that they will be completed, which could impact the company's financial stability.
- Market Reaction: Following the financing announcement, Herbalife's stock price saw a slight pre-market increase of 0.05% to $19.97, indicating cautious optimism from the market regarding its debt restructuring plans.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLF?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLF
Wall Street analysts forecast HLF stock price to rise
5 Analyst Rating
3 Buy
1 Hold
1 Sell
Moderate Buy
Current: 14.410
Low
8.00
Averages
14.60
High
20.00
Current: 14.410
Low
8.00
Averages
14.60
High
20.00
About HLF
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members. The Company has two geographical segments: Primary Reporting Segment (North America, Latin America, EMEA (Europe, Middle East, and Africa), and Asia Pacific regions) and China. Its products are classified into five categories. The Weight Management category includes meal replacements, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism-boosting teas. The Targeted Nutrition category features functional beverages and dietary supplements. The Energy, Sports, and Fitness category consists of products that support a healthy and active lifestyle. The Outer Nutrition segment offers facial skincare, body care, and hair care products. The Literature and Promotional Items include start-up kits, sales tools, and educational materials.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Acquisition Overview: Herbalife announced the acquisition of certain assets from Bioniq for $55 million, expected to close in Q2 2026, with an initial payment of $10 million and up to $95 million in contingent payments based on future performance over five years.
- Technological Integration Advantage: Bioniq's personalized supplement technology will be integrated with Herbalife's global distributor network and Pro2col's capabilities, enabling the company to offer a broader range of personalized nutritional supplements globally, enhancing market competitiveness and meeting growing consumer demand for personalization.
- Market Expansion Plans: Bioniq's personalized nutritional supplements are expected to be launched later this year through Herbalife's independent distributors in select European and U.S. markets, with plans to expand into additional markets, further strengthening Herbalife's influence in the global nutrition market.
- Enhanced Strategic Flexibility: The transaction includes a call option for Herbalife to acquire Bioniq LAB, allowing the company to evaluate potential opportunities in small molecules and peptides in a disciplined manner, thereby providing strategic support for long-term growth.
See More

Expansion of Personalized Nutrition: Herbalife is enhancing its capabilities in personalized nutritional supplements to better cater to individual health needs.
Strategic Acquisition: The company plans to achieve this expansion through the acquisition of BioNiq, a move aimed at strengthening its product offerings in the nutrition sector.
See More
- Acquisition Overview: Herbalife announced the acquisition of certain assets from UK-based Bioniq for $55 million, expected to close in Q2 2026, which will propel Herbalife's transformation into a technology-driven health platform and enhance its competitive edge in the market.
- Personalized Nutrition Expansion: Bioniq utilizes a patented product personalization engine, integrating individual health backgrounds and biomarker databases to offer personalized supplements for diverse consumers, which is anticipated to help Herbalife expand its personalized nutrition offerings globally.
- Strategic Partnership: As a long-time global nutrition partner of Herbalife, Cristiano Ronaldo supports this acquisition, emphasizing the importance of personalized nutrition in enhancing athletic performance, which is expected to further drive Herbalife's penetration in the sports nutrition market.
- Future Outlook: The acquisition includes not only Bioniq's product line but also grants Herbalife a call option to acquire Bioniq LAB, providing strategic flexibility to evaluate future opportunities in small molecules and peptides, thereby solidifying its leadership position in the personalized nutrition market.
See More
- Top Quant-Rated Companies: Herbalife (HLF) achieves a quant rating of 4.85, classified as a Strong Buy, indicating its strong valuation and profitability, which may attract investor interest and drive stock price increases.
- Strong Performers: Fresh Del Monte Produce (FDP) receives a quant rating of 4.70, also rated as a Strong Buy, suggesting its competitive edge and growth potential in the market, likely leading to increased capital inflow.
- Bottom Quant-Rated Companies: Oddity Tech (ODD) has a quant rating of 1.02, categorized as a Strong Sell, reflecting significant deficiencies in profitability and valuation, which may prompt investors to sell off its shares.
- Market Focus: As the earnings season concludes, investors are keenly interested in the quant ratings of small-cap consumer staples stocks, particularly those demonstrating strong performance in profitability and growth, which could influence overall market sentiment.
See More
- Financing Plan: Herbalife announced a plan to refinance its senior secured debt with a targeted $1.55 billion financing package, which includes a $425 million revolving credit facility, a $125 million Term Loan A, a $500 million Term Loan B, and $500 million of other secured debt, aimed at extending its debt maturity profile.
- Debt Restructuring Details: The company has initiated the refinancing process for its Term Loan B due in April 2029, under which $370 million was outstanding as of December 31, 2025, and this restructuring is expected to enhance the company's financial flexibility.
- Transaction Risk Warning: Herbalife noted that the proposed transactions are subject to customary closing conditions, and there is no assurance that they will be completed, which could impact the company's financial stability.
- Market Reaction: Following the financing announcement, Herbalife's stock price saw a slight pre-market increase of 0.05% to $19.97, indicating cautious optimism from the market regarding its debt restructuring plans.
See More
- Debt Restructuring Plan: Herbalife is targeting a refinancing of $1.55 billion in senior secured debt, which includes a $425 million revolving credit facility and $500 million in other secured debt, aimed at optimizing its capital structure and extending debt maturities to enhance financial flexibility.
- Loan Details Disclosure: The company has initiated the refinancing process for its Term Loan B maturing in April 2029, with $370 million outstanding as of December 31, 2025, and this restructuring is expected to reduce interest burdens and improve cash flow.
- Market Reaction Expectations: Although the refinancing plan is subject to customary closing conditions and allocations among debt instruments may change, a successful restructuring is anticipated to boost investor confidence and potentially have a positive impact on stock prices.
- Company Background: Since 1980, Herbalife has been committed to developing health and nutrition products, operating in over 90 markets, and the debt restructuring will support its future growth strategies, especially in the face of evolving consumer demands and market conditions.
See More









